Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 37, 3590-3593, October 1, 1977]
© 1977 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mayall, B. H.
Right arrow Articles by Rowley, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mayall, B. H.
Right arrow Articles by Rowley, J. D.

Quantification by DNA-based Cytophotometry of the 9q+/22q-Chromosomal Translocation Associated with Chronic Myelogenous Leukemia1

B. H. Mayall2, A. V. Carrano, D. H. Moore, II and J. D. Rowley

Biomedical Sciences Division, Lawrence Livermore Laboratory, Livermore, California 94550 [B. H. M., A. V. C., D. H. M.], and Department of Medicine, University of Chicago and the Franklin McLean Memorial Research Institute, Chicago, Illinois 60637 [J. D. R.]

DNA-based cytophotometry was used to analyze metaphase chromosomes in four patients with chronic myelogenous leukemia. In three of these patients, both Philadelphia chromosome (Ph1)-positive and Ph1-negative cells were measured. On the basis of these three patients, the characteristic 9q+/22q- translocation of chronic myelogenous leukemia involves the net transfer of 0.325% of the autosomal genome; there is no evidence of net gain or loss of DNA (apart from duplication of the Ph1 chromosome in one patient), and no significant difference is found in the amount of DNA transferred in different patients. Significant differences are found among patients in the derived Chromosomes 9 and the Ph1 chromosomes and are ascribed to preexisting variations in the Ph1-negative cells of these patients. There is no evidence in these patients of any further cytogenetic lesion associated with chronic myelogenous leukemia.

1 This work was performed under the auspices of the United States Energy Research and Development Administration Contract W-7405-ENG-48 and was supported in part by USPHS Grant GM-20291.

2 To whom requests for reprints should be addressed.

Received 4/ 7/77. Accepted 7/ 8/77.




This article has been cited by other articles:


Home page
ScienceHome page
J. Rowley
Identification of the constant chromosome regions involved in human hematologic malignant disease
Science, May 14, 1982; 216(4547): 749 - 751.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1977 by the American Association for Cancer Research.